Deltex Medical Group plc
("Deltex Medical" or "the Company")
Director/PDMR Share Dealing
19 June 2014 - Deltex Medical Group (AIM: DEMG), the global leader in oesophageal Doppler monitoring, announces that it has been notified that Paul Mitchell, Finance Director transferred a total of 86,750 ordinary shares of 1p each in the Company ("Ordinary Shares") into his Self Invested Personal Pension on 18 June 2014. This was effected by way of a sale of 86,750 Ordinary Shares held by Paul Mitchell at a price of 10.50 pence per Ordinary Shares. His pension fund then purchased 86,750 Ordinary Shares at a price of 10.55 pence per Ordinary Shares.
As a result of this transaction, Paul Mitchell's total beneficial holding remains unchanged at 352,831 Ordinary Shares representing 0.17% of the total issued ordinary share capital of the Company.
For further information, please contact:
Deltex Medical Group plc |
01243 774 837 |
Nigel Keen, Chairman |
investorinfo@deltexmedical.com |
Ewan Phillips, Chief Executive |
|
Paul Mitchell, Finance Director |
|
|
|
Nominated Adviser & Broker |
|
Arden Partners plc |
020 7614 5900 |
Chris Hardie |
|
|
|
Joint Broker |
|
Zeus Capital Limited |
020 7533 7727 |
Dominic Wilson |
|
John Goold |
|
|
|
Financial Public Relations |
|
Newgate Threadneedle |
020 7653 9850 |
Caroline Forde |
|
Heather Armstrong |
|